Suche starten De menü ClientConnect
Suche starten
Ergebnisse
Top-5-Suchergebnisse Alle Ergebnisse anzeigen Erweiterte Suche
Häufigste Suchbegriffe
Meistbesuchte Seiten
    Referenz: 20200266
    Veröffentlichungsdatum: 28 April 2020

    Projektträger – zwischengeschaltetes Finanzinstitut

    GALENICUM HEALTH SL

    Ort

    Beschreibung

    The project will finance the promoter's pharmaceutical RDI and expansion investments in Spain.

    Ziele

    The EIB loan will be used to support the implementation of the company's strategy. The investments are expected to support the promoter's competitiveness and growth.

    Sektor(en)

    • Industrie - Verarbeitendes Gewerbe/Herstellung von Waren

    Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)

    EUR 20 million

    Gesamtkosten (voraussichtlicher Betrag)

    EUR 50 million

    Umweltaspekte

    All aspects related to the environmental impact and permits will be verified during the project's appraisal.

    Auftragsvergabe

    The promoter has been assessed by the EIB as being a private company not operating in the utilities sector and not having a status of a contracting entity, thus not being subject to EU rule on public procurement.

    Projektstatus

    Unterzeichnet - 14/01/2021

    Haftungsausschluss

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Tags

    Spanien Industrie